| Q70221442 | ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension |
| Q34221721 | Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis |
| Q44402047 | Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics |
| Q35577195 | Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation |
| Q54397927 | Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type 1 (insulin-dependent) diabetes. |
| Q58172430 | Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycaemia in normal man |
| Q30501048 | Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man |
| Q72679455 | Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans |
| Q72877437 | Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans |
| Q39764586 | The physiological basis of insulin treatment--clinical aspects |